(Q53245453)

12 May 2018

title

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. (English)

1 reference

12 May 2018

0 references

8

Blennow K

1 reference

12 May 2018

7

Rosengren L

1 reference

12 May 2018

Magnus Sjögren

1

object named as

Sjögren M

1 reference

12 May 2018

author name string

Blomberg M

2

1 reference

12 May 2018

Jonsson M

3

1 reference

12 May 2018

Wahlund LO

4

1 reference

12 May 2018

Edman A

5

1 reference

12 May 2018

Lind K

6

1 reference

12 May 2018

Wallin A

9

1 reference

12 May 2018

publication date

1 November 2001

1 reference

12 May 2018

Journal of Neuroscience Research

published in

1 reference

12 May 2018

volume

66

1 reference

12 May 2018

page(s)

510-516

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

cites work

1 reference

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

Biological markers for the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors

21 January 2018

1 reference

Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.

21 January 2018

1 reference

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.

21 January 2018

1 reference

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

21 January 2018

1 reference

Neuropathology of white matter changes in Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates.

21 January 2018

1 reference

The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

1 reference

Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

21 January 2018

1 reference

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

21 January 2018

1 reference

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

Tau protein and the neurofibrillary pathology of Alzheimer's disease

21 January 2018

1 reference

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

1 reference

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

21 January 2018

1 reference

Leuko-araiosis and cerebral perfusion in normal aging.

21 January 2018

1 reference

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Cerebral white matter is highly vulnerable to ischemia

21 January 2018

1 reference

Pathogenesis of leukoaraiosis: a review

21 January 2018

1 reference

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

21 January 2018

1 reference

Neurofilament protein levels in CSF are increased in dementia.

21 January 2018

1 reference

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity

21 January 2018

1 reference

Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.

21 January 2018

1 reference

The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds

21 January 2018

1 reference

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

21 January 2018

1 reference

A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality

21 January 2018

1 reference

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

1 reference

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

21 January 2018

1 reference

Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.

21 January 2018

1 reference

21 January 2018

1 reference

Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

21 January 2018

1 reference

Neurofilaments in health and disease

21 January 2018

1 reference

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

21 January 2018

1 reference

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

21 January 2018

1 reference

Amyloid beta protein 1-42/43 (A beta 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study

21 January 2018

1 reference

White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia--diagnostic and pathogenetic aspects

21 January 2018

1 reference

Blood brain barrier function in vascular dementia.

21 January 2018

1 reference

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.1242

1 reference

12 May 2018

PubMed ID

11746370

1 reference

12 May 2018